HuGE Literature Finder
Records
1
-
5
Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma. BMC cancer 2023 1 23 (1): 25. Ke Changwei, Dai Shejiao, Xu Fangshi, Yuan Jia, Fan Shuting, Chen Yang, Yang Longbao, Li Yo |
Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas. Frontiers in molecular biosciences 2023 2 10 963639. Huang Wei, Wu Yuliang, Zhu Jihui, Luo Ning, Wang Chunyan, Liu Shupeng, Cheng Zhongpi |
A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. Journal of cancer research and clinical oncology 2022 11 149 (1): 203-218. Jiang Xu, Ke Jing, Jia Lifeng, An Xiang, Ma Haiyu, Li Zhongwan, Yuan W |
A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma. Journal of oncology 2022 12 2022 2124088. Zhang Kenan, Yang Wuping, Zhang Zedan, Ma Kaifang, Li Lei, Xu Yawei, Qiu Jianhui, Yu Chaojian, Zhou Jingcheng, Cai Lin, Gong Yanqing, Gong K |
Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma. Frontiers in immunology 2022 7 13 925618. Zhang Zhen, Zeng Xiangyang, Wu Yinghua, Liu Yang, Zhang Xi, Song Zew |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 29, 2023
- Content source: